Cardinal Health, Inc. (CAH)

Basic

  • Market Cap

    $27.58B

  • EV

    $27.71B

  • Shares Out

    243.23M

  • Revenue

    $216.15B

  • Employees

    47,520

Margins

  • Gross

    3.34%

  • EBITDA

    1.26%

  • Operating

    0.94%

  • Pre-Tax

    0.52%

  • Net

    0.3%

  • FCF

    1.58%

Returns (5Yr Avg)

  • ROA

    2.58%

  • ROTA

    -77.73%

  • ROE

    -44.23%

  • ROCE

    11.52%

  • ROIC

    12.92%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $113.31

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $4,591M

  • Net Debt

    $132M

  • Debt/Equity

    -1.37

  • EBIT/Interest

    31.23

Growth (CAGR)

  • Rev 3Yr

    11.38%

  • Rev 5Yr

    8.78%

  • Rev 10Yr

    8.37%

  • Dil EPS 3Yr

    -18.67%

  • Dil EPS 5Yr

    81.86%

  • Dil EPS 10Yr

    8.85%

  • Rev Fwd 2Yr

    9.53%

  • EBITDA Fwd 2Yr

    13.12%

  • EPS Fwd 2Yr

    17.57%

  • EPS LT Growth Est

    14.91%

Dividends

  • Yield

  • Payout

    78.62%

  • DPS

    $2

  • DPS Growth 3Yr

    1.16%

  • DPS Growth 5Yr

    1.1%

  • DPS Growth 10Yr

    5.38%

  • DPS Growth Fwd 2Yr

    1.87%

Select a metric from the list below to chart it

Jun '14

Jun '15

Jun '16

Jun '17

Jun '18

Jun '19

Jun '20

Jun '21

Jun '22

Jun '23

LTM

Total Revenues

145,534

152,922

162,467

181,364

205,012

216,148

Total Revenues % Chg.

6.4%

5.1%

6.2%

11.6%

13%

12%

Cost of Goods Sold, Total

138,700

146,054

155,689

174,819

198,123

208,922

Gross Profit

6,834

6,868

6,778

6,545

6,889

7,226

Selling General & Admin Expenses, Total

4,480

4,572

4,533

4,557

4,834

4,926

Amortization of Goodwill and Intangible Assets

621

524

451

324

285

270

Other Operating Expenses, Total

5,101

5,096

4,984

4,881

5,119

5,196

Operating Income

1,733

1,772

1,794

1,664

1,770

2,030

Interest Expense, Total

-294

-238

-180

-149

-93

-65

Net Interest Expenses

-294

-238

-180

-149

-93

-65

Currency Exchange Gains (Loss)

-13

-11

-8

-7

-4

Other Non Operating Income (Expenses)

-2

12

55

-16

11

21

EBT, Excl. Unusual Items

1,424

1,535

1,661

1,499

1,681

1,982

Restructuring Charges

-125

-122

-114

-101

-95

-102

Merger & Related Restructuring Charges

Impairment of Goodwill

-2,100

-1,200

-918

Gain (Loss) On Sale Of Investments

579

-2

2

Gain (Loss) On Sale Of Assets

508

-60

53

Asset Writedown

-20

-7

-19

50

-50

-60

Legal Settlements

-36

-5,741

-1,129

-109

302

174

Other Unusual Items

-16

-14

-10

EBT, Incl. Unusual Items

1,751

-3,772

323

-769

638

1,129

Income Tax Expense

386

-79

-289

163

376

488

Earnings From Continuing Operations

1,365

-3,693

612

-932

262

641

Earnings Of Discontinued Operations

Minority Interest

-2

-3

-1

-1

-1

-2

Net Income

1,363

-3,696

611

-933

261

639

Net Income to Common Incl Extra Items

1,363

-3,696

611

-933

261

639

Net Income to Common Excl. Extra Items

1,363

-3,696

611

-933

261

639

Total Shares Outstanding

299

293

291

273

251

244

Weighted Avg. Shares Outstanding

300

293

292

279

261

251.5

Weighted Avg. Shares Outstanding Dil

301

293

294

279

262

253

EPS

4.5

-12.6

2.1

-3.3

1

2.5

EPS Diluted

4.5

-12.6

2.1

-3.4

1

2.5

EBITDA

2,733

2,685

2,577

2,356

2,462

2,728